1. Uncovering the mechanisms of dandelion against triple-negative breast cancer using a combined network pharmacology, molecular pharmacology and metabolomics approach
   Jiameng Qu et al, 2022, Phytomedicine CrossRef
2. Anisi Stellati Fructus, a Significant Traditional Chinese Medicine (TCM) Herb and Its Bioactivity against Gastric Cancer
   Maryam Khan et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
3. Luteolin enhances erlotinib’s cell proliferation inhibitory and apoptotic effects in glioblastoma cell lines
   Erika Powe et al, 2022, Front. Pharmacol. CrossRef
4. Anticancer Potential of Bioactive Molecule Luteolin and Its Analogs: An Update
   N. Jeelan Basha et al, 2022, Polycyclic Aromatic Compounds CrossRef
5. SOX2 function in cancers: Association with growth, invasion, stemness and therapy response
   Sepideh Mirzaei et al, 2022, Biomedicine & Pharmacotherapy CrossRef
6. Antitumor effect of luteolin proven by patient‐derived organoids of gastric cancer
   Xinyu Hao et al, 2023, Phytotherapy Research CrossRef
7. Luteolin, a flavone ingredient: Anticancer mechanisms, combined medication strategy, pharmacokinetics, clinical trials, and pharmaceutical researches
   Mingyi Shi et al, 2023, Phytotherapy Research CrossRef
8. Flavonoids and Gastric Cancer Therapy: From Signaling Pathway to Therapeutic Significance
   Jiaying Cai et al, 2024, DDDT CrossRef
9. Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma
   Zhenzhen Yang et al, 2024, Int J Mol Med CrossRef
10. The multifaceted anticancer potential of luteolin: involvement of NF-κB, AMPK/mTOR, PI3K/Akt, MAPK, and Wnt/β-catenin pathways
    Deepika Singh et al, 2024, Inflammopharmacol CrossRef